Matrix extracellular phosphoglycoprotein (MEPE) correlates with serum phosphorus prior to and during octreotide treatment and following excisional surgery in hypophosphatemic linear sebaceous nevus syndrome.

AuthorsWilliam H Hoffman, Alka Jain, Harold Chen, Neal S Fedarko
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 146A Issue 16 Pg. 2164-8 (Aug 15 2008) ISSN: 1552-4833 [Electronic] United States
PMID18627046 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Extracellular Matrix Proteins
  • Glycoproteins
  • MEPE protein, human
  • Phosphoproteins
  • fibroblast growth factor 23
  • Phosphorus
  • Fibroblast Growth Factors
  • Calcitriol
  • Octreotide
  • Adolescent
  • Calcitriol (therapeutic use)
  • Extracellular Matrix Proteins (blood)
  • Fibroblast Growth Factors (blood)
  • Glycoproteins (blood)
  • Humans
  • Hypophosphatemia (drug therapy)
  • Male
  • Nevus, Sebaceous of Jadassohn (surgery)
  • Octreotide (therapeutic use)
  • Phosphoproteins (blood)
  • Phosphorus (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: